Trial · NCT07913828
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of Clinically Significant Post-Spinal Shivering (Crossley-Mahajan Grade ≥3) | From immediately after spinal anesthesia until 60 minutes after spinal anesthesia | |
| Secondary | Severity of Post-Spinal Shivering (Crossley-Mahajan Grade 0-4) | From immediately after spinal anesthesia until 60 minutes after spinal anesthesia | |
| Secondary | Time to Onset of Post-Spinal Shivering | From immediately after spinal anesthesia until the first occurrence of shivering, assessed for up to 60 minutes after spinal anesthesia. | |
| Secondary | Cumulative Dose of Intravenous Pethidine Used as Rescue Treatment for Post-Spinal Shivering | From the onset of clinically significant shivering until discharge from the recovery room. | Cumulative dose of intravenous pethidine administered as rescue treatment for clinically significant shivering (Crossley-Mahajan Grade ≥3). |
| Secondary | Systolic, Diastolic, and Mean Arterial Blood Pressure | Immediately before spinal anesthesia (baseline), and at 0, 5, 10, 15, 20, 25, 30, 45, and 60 minutes after spinal anesthesia. | |
| Secondary | Heart rate | Immediately before spinal anesthesia (baseline), and at 0, 5, 10, 15, 20, 25, 30, 45, and 60 minutes after spinal anesthesia. | |
| Secondary | Core Body Temperature | Immediately before spinal anesthesia (baseline), and at 0, 5, 10, 15, 20, 25, 30, 45, and 60 minutes after spinal anesthesia. | |
| Secondary | Sedation Score Assessed Using the Modified Ramsay Sedation Scale | Immediately before spinal anesthesia (baseline), and at 0, 5, 10, 15, 20, 25, 30, 45, and 60 minutes after spinal anesthesia. | |
| Secondary | Apgar Score at 1 and 5 Minutes After Birth | At 1 and 5 minutes after birth. | |
| Secondary | Need for Neonatal Respiratory Support | From birth through 24 hours after birth. | |
| Secondary | Neonatal Intensive Care Unit (NICU) Admission | From birth through 24 hours after birth. | |
| Secondary | Incidence of Maternal Adverse Effects | From initiation of study drug administration through 24 hours after delivery. | Incidence of hypotension, bradycardia, respiratory depression, nausea, vomiting, and flushing. |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07913828/registered